Mandate

EQT acquires MTU from DaimlerChrysler

July 19, 2006

EQT has signed an agreement with DaimlerChrysler to purchase 100% of the German engine manufacturer MTU Friedschafen GmbH.  The MTU group's operations consist of manufacturing and designing diesel engines and driving systems for boats, armoured vehicles, etc.
The acquisition was reviewed by authorities in terms of competition and Vinge acted as advisor in this area.

Representatives from Vinge included Johan Karlsson, Ulrika Wester, Pernilla Olsson and Hanna Eklinder.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026